EE200300485A - Tiohüdantoinid ja nende kasutamine diabeedi raviks - Google Patents
Tiohüdantoinid ja nende kasutamine diabeedi raviksInfo
- Publication number
- EE200300485A EE200300485A EEP200300485A EEP200300485A EE200300485A EE 200300485 A EE200300485 A EE 200300485A EE P200300485 A EEP200300485 A EE P200300485A EE P200300485 A EEP200300485 A EE P200300485A EE 200300485 A EE200300485 A EE 200300485A
- Authority
- EE
- Estonia
- Prior art keywords
- thiohydantoin
- diabetes
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0104552A FR2823209B1 (fr) | 2001-04-04 | 2001-04-04 | Nouvelles thiohydantoines et leur utilisation en therapeutique |
PCT/FR2002/001167 WO2002081453A1 (fr) | 2001-04-04 | 2002-04-04 | Hiohydantoïnes et leur utilisation dans le traitement du diabete |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200300485A true EE200300485A (et) | 2004-02-16 |
Family
ID=8861916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200300485A EE200300485A (et) | 2001-04-04 | 2002-04-04 | Tiohüdantoinid ja nende kasutamine diabeedi raviks |
Country Status (21)
Country | Link |
---|---|
US (1) | US20040116417A1 (fr) |
EP (1) | EP1373219A1 (fr) |
JP (1) | JP2004525175A (fr) |
KR (1) | KR20030085565A (fr) |
CN (1) | CN1500081A (fr) |
BG (1) | BG108225A (fr) |
BR (1) | BR0207910A (fr) |
CA (1) | CA2444024A1 (fr) |
CZ (1) | CZ20032696A3 (fr) |
EE (1) | EE200300485A (fr) |
FR (1) | FR2823209B1 (fr) |
HU (1) | HUP0401537A3 (fr) |
IL (1) | IL158195A0 (fr) |
MX (1) | MXPA03009083A (fr) |
NO (1) | NO20034430L (fr) |
PL (1) | PL364904A1 (fr) |
RU (1) | RU2003129532A (fr) |
SK (1) | SK12332003A3 (fr) |
WO (1) | WO2002081453A1 (fr) |
YU (1) | YU75903A (fr) |
ZA (1) | ZA200307372B (fr) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050119251A1 (en) * | 2001-12-21 | 2005-06-02 | Jian-Min Fu | Nicotinamide derivatives and their use as therapeutic agents |
ATE548354T1 (de) | 2002-07-24 | 2012-03-15 | Ptc Therapeutics Inc | Ureido-substituierte benzoesäureverbindungen und ihre verwendung für die nonsense-suppression und behandlung von erkrankungen |
ITMI20022748A1 (it) * | 2002-12-23 | 2004-06-24 | Eurand Int | Dispersioni solide stabilizzate di farmaco in un carrier organico e procedimento per la loro preparazione. |
EP1651606B1 (fr) * | 2003-07-30 | 2012-10-24 | Xenon Pharmaceuticals Inc. | Derives pyridyle et leur utilisation en tant qu'agents therapeutiques |
EP2316827B1 (fr) * | 2003-07-30 | 2016-01-27 | Xenon Pharmaceuticals Inc. | Derives de piperazine et leurs utilisations en tant qu'agents therapeutiques |
EP2299266A1 (fr) * | 2003-12-19 | 2011-03-23 | The Regents of the University of California | Procédés et matériels pour évaluer les thérapies du cancer de la prostate |
US7718684B2 (en) * | 2004-02-24 | 2010-05-18 | The Regents Of The University Of California | Methods and materials for assessing prostate cancer therapies and compounds |
DE102004024011A1 (de) * | 2004-05-14 | 2005-12-01 | Bayer Chemicals Ag | Difluorbenzo-1,3-dioxole |
CN101084207A (zh) * | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 杂环衍生物及其作为硬脂酰CoA去饱和酶抑制剂的用途 |
BRPI0515488A (pt) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados de heterocìclicos e seu uso como agentes terapêuticos |
MX2007003318A (es) | 2004-09-20 | 2007-05-18 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como agentes terapeuticos. |
EP2269610A3 (fr) | 2004-09-20 | 2011-03-09 | Xenon Pharmaceuticals Inc. | Dérivés hétérocycliques et leur utilisation en tant qu'inhibiteurs de la stearoyl-coa desaturase |
JP5080256B2 (ja) * | 2004-09-20 | 2012-11-21 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 二環式複素環誘導体およびステアロイル−CoAデサチュラーゼ(SCD)のインヒビターとしてのそれらの使用 |
CA2580845A1 (fr) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Derives heterocycliques et leur utilisation en tant qu'agents therapeutiques |
AU2005286647A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
MX2007003327A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos, y su uso como mediadores de estearoil-coa desaturasa. |
BRPI0515499A (pt) * | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados de piridina para a inibição de estearoil-coa-desaturase humana |
US7709517B2 (en) | 2005-05-13 | 2010-05-04 | The Regents Of The University Of California | Diarylhydantoin compounds |
JP2009513563A (ja) | 2005-06-03 | 2009-04-02 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | ヒトのステアロイル−CoAデサチュラーゼ阻害剤としてのアミノチアゾール誘導体 |
PL3100727T3 (pl) | 2006-03-27 | 2019-01-31 | The Regents Of The University Of California | Modulator receptora androgenowego do leczenia raka gruczołu krokowego i chorób związanych z receptorem androgenowym |
AU2016201061B2 (en) * | 2006-03-27 | 2017-03-02 | The Regents Of The University Of California | Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |
KR20160027254A (ko) * | 2006-03-29 | 2016-03-09 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 디아릴티오히단토인 화합물 |
TW200815428A (en) | 2006-08-15 | 2008-04-01 | Wyeth Corp | Oxazolidone derivatives as PR modulators |
US7649007B2 (en) | 2006-08-15 | 2010-01-19 | Wyeth Llc | Oxazolidine derivatives as PR modulators |
US7538107B2 (en) | 2006-08-15 | 2009-05-26 | Wyeth | Oxazinan-2-one derivatives useful as PR modulators |
WO2008021309A1 (fr) | 2006-08-15 | 2008-02-21 | Wyeth | Dérivés d'imidazolidin-2-one utiles en tant que modulateurs pr |
US7618989B2 (en) | 2006-08-15 | 2009-11-17 | Wyeth | Tricyclic oxazolidone derivatives useful as PR modulators |
FR2917735B1 (fr) * | 2007-06-21 | 2009-09-04 | Sanofi Aventis Sa | Nouveaux indazoles substitutes, leur preparation et leur utilisation en therapeutique |
CA2703635C (fr) | 2007-10-26 | 2017-06-27 | Michael E. Jung | Composes de diarylhydantoine en tant que modulateurs des recepteurs androgenes |
BRPI0913291A2 (pt) | 2008-05-30 | 2019-01-15 | Takeda Pharmaceuticals Co | composto, pró-droga, medicamento, métodos para diminuir a proteína 4 ou tratamento de diabete em um mamífero, e, uso do composto |
US8937060B2 (en) | 2009-05-12 | 2015-01-20 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders |
CA2787083C (fr) * | 2010-02-16 | 2018-05-22 | Aragon Pharmaceuticals, Inc. | Modulateurs du recepteur des androgenes et leurs utilisations |
MX2012009782A (es) * | 2010-02-24 | 2012-11-29 | Medivation Prostate Therapeutics Inc | Procesos para la sintesis de diariltiohidantoina y compuestos de diarilhidantoina. |
WO2013067142A1 (fr) * | 2011-11-02 | 2013-05-10 | Medivation Technologies, Inc. | Composés et méthodes de traitement |
CN109908114A (zh) | 2012-09-26 | 2019-06-21 | 阿拉贡药品公司 | 用于治疗非转移性去势抵抗性前列腺癌的抗雄激素 |
JOP20200097A1 (ar) | 2013-01-15 | 2017-06-16 | Aragon Pharmaceuticals Inc | معدل مستقبل أندروجين واستخداماته |
ITUB20151256A1 (it) | 2015-05-28 | 2016-11-28 | Olon Spa | Processo industriale per la preparazione di enzalutamide |
TWI726969B (zh) | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物 |
AU2018351714A1 (en) | 2017-10-16 | 2020-04-30 | Aragon Pharmaceuticals, Inc. | Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer |
WO2022206742A1 (fr) * | 2021-03-30 | 2022-10-06 | 苏州开拓药业股份有限公司 | Procédé de synthèse d'un dérivé de thiohydantoïne au moyen d'un procédé en une étape |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2551134A (en) * | 1947-05-15 | 1951-05-01 | Du Pont | Process of color developing with 2-thiohydantoin derivatives |
US3923994A (en) * | 1973-07-13 | 1975-12-02 | Smithkline Corp | Anti-arthritic compositions comprising a 3-aryl 2-thiohydantoin and methods of producing anti-arthritic acitvity |
GB1472467A (en) * | 1974-04-19 | 1977-05-04 | Wyeth John & Brother Ltd | Thiohydantoins |
US4473393A (en) * | 1982-08-06 | 1984-09-25 | Buffalo Color Corporation | Pesticidal thiohydantoin compositions |
US4743611A (en) * | 1986-07-02 | 1988-05-10 | American Home Products Corp. | Naphthalenylsulfonylimidazolidinediones and their thioxo analogs useful as aldose reductase inhibitors |
US5821372A (en) * | 1995-11-28 | 1998-10-13 | American Home Products Corporation | 2-thioxo-imidazolidin-4-one derivatives |
US5554607A (en) * | 1995-11-28 | 1996-09-10 | American Home Products Corporation | Use of 2-thioxo-imidazolin-4-one derivatives in the treatment of atherosclerosis |
DE19741235A1 (de) * | 1997-09-18 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
-
2001
- 2001-04-04 FR FR0104552A patent/FR2823209B1/fr not_active Expired - Fee Related
-
2002
- 2002-04-04 JP JP2002579441A patent/JP2004525175A/ja not_active Withdrawn
- 2002-04-04 RU RU2003129532/04A patent/RU2003129532A/ru not_active Application Discontinuation
- 2002-04-04 BR BR0207910-0A patent/BR0207910A/pt not_active Application Discontinuation
- 2002-04-04 CZ CZ20032696A patent/CZ20032696A3/cs unknown
- 2002-04-04 WO PCT/FR2002/001167 patent/WO2002081453A1/fr not_active Application Discontinuation
- 2002-04-04 IL IL15819502A patent/IL158195A0/xx unknown
- 2002-04-04 KR KR10-2003-7012356A patent/KR20030085565A/ko not_active Application Discontinuation
- 2002-04-04 SK SK1233-2003A patent/SK12332003A3/sk unknown
- 2002-04-04 US US10/473,032 patent/US20040116417A1/en not_active Abandoned
- 2002-04-04 CA CA002444024A patent/CA2444024A1/fr not_active Abandoned
- 2002-04-04 EP EP02730333A patent/EP1373219A1/fr not_active Withdrawn
- 2002-04-04 PL PL02364904A patent/PL364904A1/xx not_active Application Discontinuation
- 2002-04-04 YU YU75903A patent/YU75903A/sh unknown
- 2002-04-04 EE EEP200300485A patent/EE200300485A/xx unknown
- 2002-04-04 CN CNA028075811A patent/CN1500081A/zh active Pending
- 2002-04-04 MX MXPA03009083A patent/MXPA03009083A/es unknown
- 2002-04-04 HU HU0401537A patent/HUP0401537A3/hu unknown
-
2003
- 2003-09-22 ZA ZA200307372A patent/ZA200307372B/en unknown
- 2003-10-03 NO NO20034430A patent/NO20034430L/no not_active Application Discontinuation
- 2003-10-03 BG BG108225A patent/BG108225A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NO20034430L (no) | 2003-10-06 |
YU75903A (sh) | 2006-05-25 |
NO20034430D0 (no) | 2003-10-03 |
WO2002081453A8 (fr) | 2002-11-14 |
BG108225A (en) | 2005-04-30 |
BR0207910A (pt) | 2004-08-03 |
SK12332003A3 (sk) | 2004-04-06 |
EP1373219A1 (fr) | 2004-01-02 |
HUP0401537A3 (en) | 2005-06-28 |
ZA200307372B (en) | 2004-09-22 |
JP2004525175A (ja) | 2004-08-19 |
RU2003129532A (ru) | 2005-04-10 |
CA2444024A1 (fr) | 2002-10-17 |
CN1500081A (zh) | 2004-05-26 |
WO2002081453A1 (fr) | 2002-10-17 |
FR2823209B1 (fr) | 2003-12-12 |
MXPA03009083A (es) | 2004-11-22 |
US20040116417A1 (en) | 2004-06-17 |
FR2823209A1 (fr) | 2002-10-11 |
KR20030085565A (ko) | 2003-11-05 |
IL158195A0 (en) | 2004-03-28 |
CZ20032696A3 (cs) | 2003-12-17 |
HUP0401537A2 (hu) | 2005-01-28 |
PL364904A1 (en) | 2004-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200300485A (et) | Tiohüdantoinid ja nende kasutamine diabeedi raviks | |
DE50009607D1 (de) | Substituierte oxazolidinone und ihre verwendung im gebiet der blutgerinnung | |
DE60222671D1 (de) | Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen | |
EE05507B1 (et) | Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks | |
DE60209486D1 (de) | Pyranoindazole und ihre verwendung in der glaukombehandlung | |
EE05073B1 (et) | Retigabiin kasutamiseks neuropaatilise valu ravis | |
IL160917A0 (en) | Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions | |
EE200100480A (et) | Ksenoon kasutamiseks närvimürgistuste ravis | |
EE200500011A (et) | Indasoolid, bensotiasoolid ja bensoisotiasoolid, nende valmistamine ning kasutamine | |
EE200300311A (et) | Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim | |
DK1411064T3 (da) | Gangliosid-associerede rekombinante antistoffer og anvendelsen deraf i diagnosen og behandlingen af tumorer | |
EE200300545A (et) | 4-(fenüülpiperasinüülmetüül)bensamiidi derivaadid, nende valmistamine ja kasutamine valu, ärevuse ja seedetrakti häirete ravis | |
NO20034159D0 (no) | Östrogen-gestagen-kombinasjonspreparat og anvendelse derav | |
EE200300473A (et) | Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks | |
IS7348A (is) | N-pýrasínýl-fenýlsúlfónamíð og notkun þeirra til að meðhöndla flakkboðatengda sjúkdóma | |
EE200300474A (et) | Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks | |
NO20041214L (no) | Substituerte benzimidazolforbindelser og deres anvendelse for behandling av cancer | |
DE60223576D1 (de) | Hautbehandlungszusammensetzung | |
DE60216376D1 (de) | Verbundklebstoff und dessen Verwendung | |
EE200300328A (et) | IL-18 inhibiitorite kasutamine südamehaiguse raviks ja/või ennetamiseks | |
DK1461042T3 (da) | Anvendelse af desoxypeganin til behandling af klinisk depression | |
EE200300454A (et) | Bitsüklilised guanidiini derivaadid ja nende terapeutiline kasutamine | |
PT1381620E (pt) | Dissacaridos hipersulfatados e metodos de utilizacao dos mesmos para o tratamento de inflamacoes | |
DE50301665D1 (de) | Torblatthandgriff sowie Verwendung desselben | |
PT1496884E (pt) | Associacao de um antitrombotico e de aspirina e sua utilizacao no tratamento das doencas tromboticas aterosclerosas. |